Brian Casey and Wayne Forrest[email protected]Clinical NewsPull linear MRI contrast from market, European group saysIn a stunning development, a European Union regulatory body on Friday recommended that four gadolinium-based contrast agents for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur. The agents affected include some of the most widely used contrast products in medical imaging.March 9, 2017Page 1 of 1Top StoriesNuclear MedicineSPECT, PET refine contemporary cardiac amyloidosis assessmentExperts highlighted SPECT/SPECT-CT as central to reliable cardiac amyloidosis imaging, while emerging PET tracers may improve early detection, disease characterization, and follow-up.UltrasoundAdvanced ultrasound techniques improve soft tissue tumor evaluationHomeLeimgruber: Nuclear medicine needs regulation fit for innovationHomeSuhny Abbara talks AI in scientific publishingRadiation Oncology/TherapyRadiotherapy access could address gynecological cancer disparities